Recruiting Clinical Trials

Displaying 1 - 10 of 220 result(s)
Study Title Condition Phase Location
A Randomized, Double-blind, Phase III Study, Comparing NIS793 in Combination With Gemcitabine and Nab-paclitaxel Versus (vs.) Placebo Combined With Gemcitabine and Nab-paclitaxel for First Line Treatment of Metastatic Pancreatic Ductal Adenocarcinoma ... Metastatic Pancreatic Ductal Adenocarcinoma Phase 3
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Belgium
  • Country: 
    More locations
An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabrafenib) and/or Mekinist (Trametinib) Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma, Oligodendroglioma, Childhood, Anaplastic Oligodendroglioma, Glioblastoma, Pilocytic Astrocytoma, Giant Cell Astrocytoma, Pleomorphic Xanthoastrocytoma, Anaplastic Pleomorphic Xanthoastrocytoma, Angiocentric Glioma, Chordoid Glioma of Third Ventricle, Gangliocytoma, Ganglioglioma, Anaplastic Ganglioglioma, Dysplastic Gangliocytoma of Cerebrellum, Desmoplastic Infantile Astrocytoma and Ganglioglioma, Papillary Glioneuronal Tumor, Rosette-forming Glioneurona Tumor, Central Neurocytoma, Extraventricular Neurocytoma, Cerebellar Liponeurocytoma, Neurofibromatosis Type 1 Phase 4
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Belgium
  • Country: 
    More locations
A Participant- and Investigator-blinded, Randomized, Placebo-controlled, Multicenter, Platform Study to Investigate Efficacy, Safety, and Tolerability of Various Single Treatments in Participants With Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis Phase 2
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
A Randomized, Controlled, Open Label, Phase III Study Evaluating the Efficacy and Safety of JDQ443 Versus Docetaxel in Previously Treated Subjects With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer Non-Small Cell Lung Cancer Phase 3
  • Country: 
    Argentina
  • Country: 
    Bulgaria
  • Country: 
    Croatia
  • Country: 
    More locations
A Phase IIIb, Multi-center, Open-label, Randomized Study of Tolerability and Efficacy of Oral Asciminib Versus Nilotinib in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase. Philadelphia Chromosome-Positive Chronic Myeloid Leukemia Phase 3
  • Country: 
    Bulgaria
  • Country: 
    Czech Republic
  • Country: 
    France
  • Country: 
    More locations
A Phase II, Single-arm Study of De-escalation and Treatment-free Remission in Patients With Chronic Myeloid Leukemia Treated With Nilotinib in First-line Therapy Followed by a Second Attempt After Nilotinib and Asciminib Combination: DANTE Study Chronic Myeloid Leukemia Phase 2
  • Country: 
    Italy
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) Primary Prevention of Atherosclerotic Cardiovascular Disease Phase 3
  • Country: 
    United States
  • Country: 
    Canada
A Special Drug Use-results Survey to Evaluate the Safety and Efficacy of Subcutaneous Administration of Cosentyx in Pediatric Patients With Psoriasis Vulgaris, Psoriatic Arthritis, or Pustular Psoriasis Psoriasis Vulgaris, Psoriatic Arthritis, Pustular Psoriasis Not Given
  • Country: 
    Japan
A Double-blind, Randomized, Placebo- and Active-Comparator Controlled Study to Evaluate the Efficacy of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-Lowering Therapy (VictORION-Mono) Hypercholesterolemia Phase 3
  • Country: 
    United States
An Open-label, Single Arm, Multicenter Extension Study to Evaluate Long-term Safety and Tolerability of Inclisiran in Participants With Heterozygous or Homozygous Familial Hypercholesterolemia Who Have Completed the Adolescent ORION-16 or ORION-13 St ... Heterozygous or Homozygous Familial Hypercholesterolemia Phase 3
  • Country: 
    United States
  • Country: 
    Hungary
  • Country: 
    Norway